Large granular lymphoma in six cats

Insights

Large granular lymphoma (LGL) is a common feline cancer, often diagnosed via cytology. Conventional chemotherapy offers a better prognosis than glucocorticoids for cats with LGL.

Area of Science:

  • Veterinary Oncology
  • Hematopathology

Background:

  • Large granular lymphoma (LGL) is a distinct lymphoma category characterized by neoplastic cells with visible cytoplasmic granules.
  • Feline LGLs present in various forms, including nasal, systemic, and alimentary.

Purpose of the Study:

  • To document clinical and cytological data of feline LGL.
  • To analyze therapeutic responses in treated feline LGL cases.

Main Methods:

  • Retrospective case review of six cats diagnosed with LGL between 2012-2014.
  • Cytological sample collection via fine-needle biopsy for diagnosis.
  • Treatment analysis including palliative glucocorticoids, COP chemotherapy, and masitinib.

Main Results:

  • Alimentary form was most common (4/6 cats).
  • Median survival: 9 months for chemotherapy, 1.5 months for glucocorticoids.
  • Conventional chemotherapy showed good response in some cases.

Conclusions:

  • Feline LGL, particularly the alimentary form, is relatively common.
  • Standard diagnostic methods (clinical, imaging, cytology) are sufficient.
  • Conventional chemotherapy can yield positive outcomes despite aggressive nature.